Skip to main content

Identify underlying cause of hirsutism and individualize treatment as required

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Diagnostic evaluation of women with hirsutism is essential to identify and manage the underlying cause of the condition, which is often an endocrine disorder. Physical and pharmacological treatments for hirsutism are available, and should be individualized according to the needs and preferences of the patient, the severity and extent of hirsutism, and the potential benefits and harms of therapy.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Somani N, Turvy D. Hirsutism: an evidence-based treatment update. Am J Clin Dermatol. 2014;15(3):247–66.

    PubMed  Article  Google Scholar 

  2. 2.

    Richards RN, Meharg GE. Electrolysis: observation from 13 years and 140,000 h of experience. J Am Acad Dermatol. 1995;33(4):662–6.

    CAS  PubMed  Article  Google Scholar 

  3. 3.

    Kligman AM, Peters L. Histologic changes of human hair follicles after electrolysis: a comparison of two methods. Cutis. 1984;34(2):169–76.

    CAS  PubMed  Google Scholar 

  4. 4.

    Thaysen-Petersen D, Bjerring P, Dierickx C, et al. A systematic review of light-based home-use devices for hair removal and considerations on human safety. J Eur Acad Dermatol Venereol. 2012;26(5):545–53.

    CAS  PubMed  Article  Google Scholar 

  5. 5.

    Haedersdal M, Wolf HC. Evidence-based review of hair removal using lasers and light sources. J Eur Acad Dermatol Venereol. 2006;20(1):9–20.

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    Eremia S, Li C, Newman N. Laser hair removal with alexandrite versus diode laser using four treatment sessions: 1-year results. Dermatol Surg. 2001;27(11):925–9.

    CAS  PubMed  Google Scholar 

  7. 7.

    Lapidoth M, Dierickx C, Lanigan S, et al. Best practice options for hair removal in patients with unwanted facial hair using combination therapy with laser: guidelines drawn up by an expert working group. Dermatology. 2010;221(1):34–42.

    CAS  PubMed  Article  Google Scholar 

  8. 8.

    Martin KA, Chang RJ, Ehrmann DA, et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(4):1105–20.

    CAS  PubMed  Article  Google Scholar 

  9. 9.

    Lidegarrd Ø, Nielsen LH, Skovlund CW, et al. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001–2009. BMJ. 2011;343:d6423.

    Article  Google Scholar 

  10. 10.

    Swiglo BA, Cosma M, Flynn DN, et al. Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab. 2008;93(4):1153–60.

    PubMed  Article  Google Scholar 

  11. 11.

    Belisle S, Love EJ. Clinical efficacy and safety of cyproterone acetate in severe hirsutism: results of a multicentered Canadian study. Fertil Steril. 1986;46(6):1015–20.

    CAS  PubMed  Google Scholar 

  12. 12.

    Cosma M, Swiglo BA, Flynn DN, et al. Insulin sensitizers for the treatment of hirsuitsm: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab. 2008;93(4):1135–42.

    CAS  PubMed  Article  Google Scholar 

  13. 13.

    Escobar-Morreale HF, Carmina E, Dewailly D, et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2012;18(2):146–70.

    CAS  PubMed  Article  Google Scholar 

  14. 14.

    Moran LJ, Hitchison SK, Norman RJ, et al. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Databse Syst Rev. 2011(7):CD007506.

  15. 15.

    Thomson RL, Spedding S, Buckley JD. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012;77(3):343–50.

    CAS  PubMed  Article  Google Scholar 

Download references

Disclosure

This article was adapted from the American Journal of Clinical Dermatology 2014;15(3):247–66 [1] by salaried/contracted employees of Adis/Springer. The preparation of these articles was not supported by any external funding.

Author information

Affiliations

Consortia

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Adis Medical Writers. Identify underlying cause of hirsutism and individualize treatment as required. Drugs Ther Perspect 30, 417–421 (2014). https://doi.org/10.1007/s40267-014-0159-8

Download citation

Keywords

  • Pituitary Adenoma
  • Acromegaly
  • Congenital Adrenal Hyperplasia
  • Finasteride
  • Hyperandrogenism